Proliferation arrest and induction of CDK inhibitors p21 and p27 by depleting the calcium store in cultured C6 gliomca cells

European Journal of Cell Biology

Volumn 78, Issue 11, 1999, Pages 824-831

  Chen, Yu Jen ^a   Lin, Jen Kun ^a   Lin Shiau, Shoei Yn ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

C6 glioma; Ca2+ depletion; CDK inhibitor; Morphology change; Proliferation arrest

Indexed keywords

CALCIUM ION; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GLIOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPINDLE CELL;

ANIMALIA;

EID: 0032728866     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-9335(99)80033-8     Document Type: Article

References (53)

1. Banerjee, D., Lenz, H.-J., Schnieders, B., Manno, D. J., Ju, J. F., Spears, C. P., Hochhauser, D., Danenberg, K., Danenberg, P., Bertino, J. R.: Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stress. Cell Growth Diff. 6, 1405-1413 (1995).
2. 2+ entry. Cell Calcium 17, 207-215 (1995).
3. Berridge, M. J., Irvine, R. F.: Inositol phosphates and cell signalling. Nature (Lond.) 341, 197-205 (1989).
4. Bian, J. H., Ghosh, T. K., Wang, J. C., Gill, D. L.: Identification of intracellular calcium pools. Selective modification by thapsigargin. J. Biol. Chem. 266, 8801-8806 (1991).
5. 2 in the glioma cell line C6. Anticancer Res. 11, 289-296 (1991).
6. Datto, M. B., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y., Wang, X. F.: Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92, 545-549 (1995).
7. Draetta, G.: Cell cycle control in eukaryotes: molecular mechanisms of cdc2 activation. Trends Biol. Sci. 15, 378-383 (1990).
8. El-Deiry, W. S., Tokino, X., Velculescu, V. E., Leny, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., Vogelstein, B.: WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
9. Furuichi, T., Yoshikawa, S., Miyawaki, A., Wada, K., Maeda, N., Mikoshiba, K.: Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400. Nature (Lond.) 342, 32-38 (1989).
10. Ghosh, T. K., Eis, P. S., Mullaney, J. M., Ebert, C. L., Gill, D. L.: Competitive, reversible, and potent antagonism of inositol 1,4,5-trisphosphate-activated calcium release by heparin. J. Biol. Chem. 263, 11075-11079 (1988).
11. Ghosh, T. K., Bian, J., Short, A. D., Rybak, S. L., Gill, D. L.: Persistent intracellular calcium pool depletion by thapsigargin and its influence on cell growth. J. Biol. Chem. 266, 24690-24697 (1991).
12. Grana, X., Reddy, E. P.: Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11, 211-219 (1995).
13. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., Lassar, A. B.: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267, 1081-1021 (1995).
14. 2+ gradients lengthens the duration of the cell cycle in Xenopus laevis blastomeres. J. Cell Biol. 116, 147-156 (1992).
15. Hardingham, G. E., Sangeeta, C., Johnson, C. M., Bading, H.: Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 385, 260-265 (1997).
16. 1 cyclin-dependent kinases. Cell 75, 805-816 (1993).
17. 1 phase cyclin-dependent kinase without altering mitogen-activated protein kinase stimulation. J. Biol. Chem. 271, 9376-9383 (1996).
18. 2+]dynamics measured in agonist-sensitive stores of single living intact cells: a new look at the refilling process. EMBO J. 17, 1986-1995 (1998).
19. Jeoung, D. I., Tang, B., Sonenberg, M.: Induction of tumor suppressor p21 protein by kinase inhibitors in MCF-7 cells. Biochem. Biophys. Res. Commun. 214, 361-366 (1995).
20. 2+-ATPaSe inhibitor thapsigargin. Exp. Cell Res. 212, 84-92 (1994).
21. Kaneko, Y., Tsukamoto, A.: Thapsigargin-induced persistent intracellular calcium pool depletion and apoptosis in human hepatoma cells. Cancer Lett. 79, 147-155 (1994).
22. 2+ in mitotic progression of Swiss 3T3 fibroblasts. J. Cell Biol. 111, 183-196 (1990).
23. 2+ fluxes. Proc. Natl. Acad. Sci. USA 91, 6569-6573 (1994).
24. Lee, M. A., Dunn, R. C., Clapham, D. E., Stehno-Bittel, L.: Calcium regulation of nuclear pore permeability. Cell Calcium 23:91-101 (1998).
25. Lee, K., Kentroti, S., Billie, H., Bruce, C., Vernadakis, A.: Comparative biochemical, morphological, and immunocytochemical studies between C-6 glial cells of early and late passages and advanced passages of glial cells derived from aged mouse cerebral hemispheres. Glia 6, 245-257 (1992).
26. Lowe, S. W., Ruley, H. E., Jacks, T., Housman, D. E.: p53 dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-967 (1993).
27. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., Jacks, T.: p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9, 935-944 (1995).
28. McCormick, T. S., McColl, K. S., Distelhorst, C. W.: Mouse lymphoma cells destined to undergo apoptosis in response to thapsigargin treatment fail to generate a calcium-mediated grp78/grp94 stress response. J. Biol. Chem. 272, 6087-6092 (1997).
29. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., Givol, D.: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54, 3391-3395 (1994).
30. 2+ concentration in the store lumen. EMBO J. 17, 435-442 (1998).
31. 2+ sequestration. FEBS Lett. 224, 331-336 (1987).
32. Morgan, D. O.: Principles of CDK regulation. Nature 374, 131-134 (1995).
33. Perez-Terzic, C., Jaconi, M., Clapham, D. E.: Nuclear calcium and the regulation of the nuclear pore complex. Bioassays 19, 787-792 (1997).
34. Petersen, O. H., Gerasimenko, O. V., Gerasimenko, H. M., Tepikin, A. V.: The calcium store in the nuclear envelope. Cell Calcium 23, 87-90 (1998).
35. Pines, J.: Cyclins and cyclin-dependent kinases: take your partners. Trends Biochem Sci. 18, 195-197 (1993).
36. Polyak, K., Lee, M. H., Erdjument, B. H., Koff, A., Roberts, J. M., Tempst, P., Massague, J.: Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66 (1994).
37. Rossier, M. F., Putney, J. W., Jr.: The identity of the calcium-storing, inositol 1,4,5-trisphosphate-sensitive organelle in non-muscle cells: calciosome, endoplasmic reticulum...or both? Trends Neurosci. 14, 310-314 (1991).
38. Scharfen, C. O., Sneed, P. K., Wara, W. M., Larson, D. A., Phillips, T. L., Prados, M. D., Weaver, K. A., Malec, M., Acord, P., Lamborn, K. R.: High activity iodine-125 interstitial implant for gliomas. Int. J. Radiat. Oncol. Biol. Phys. 24, 583-591 (1992).
39. Schwaller, J., Koeffier, H. P., Niklaus, G., Loetscher, P., Nagel, S., Fey, M. F., Tobler, A.: Posttranscription stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells. J. Clin. Invest. 95, 973-979 (1995).
40. Sharma, S. K., Raj, A. B.: Transient increase in intracellular concentration of adenosine 3′:5′-cyclic monophosphate results in morphological and biochemical differentiation of C6 glioma cells in culture. J. Neurosci. Res. 17, 135-141 (1987).
41. 1 cyclins. Cell 73, 1059-1065 (1993).
42. 1 cyclin-dependent kinase. Genes Dev. 9, 1149-1163 (1995).
43. Steinhardt, R. A., Alderton, J.: Intracellular free calcium rise triggers nuclear envelope breakdown in the sea urchin embryo. Nature (Lond.) 332, 364-366 (1988).
44. Takemura, H., Hughes, A. R., Thastrup, O., Putney, J. W., Jr.: Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. Evidence that an intracellular calcium pool and not an inositol phosphate regulates calcium fluxes at the plasma membrane. J. Biol. Chem. 264, 12266-12271 (1989).
45. Taylor, C. W.: In: Habenicht, A. (ed.): Growth Factors, Differentiation Factors, and Cytokines, pp. 383-394, Springer, Berlin 1990.
46. Thastrup, O., Dawson, A. P., Scharff, O., Foder, B., Cullen, P. J., Drobak, B. K., Bjerrum, P. J., Christensen, S. B., Hanley, M. R.: Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage. Agents Actions 27, 17-23 (1989).
47. 1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74 (1994).
48. Wallner, K. E., Galicich, J. H., Krol, G., Malkin, M. G., Arbit, E.: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int. J. Radiat. Oncol. Biol. Phys. 16, 1405-1409 (1989).
49. Whitaker, M., Patel, R.: Calcium and cell cycle control. Development 108, 525-542 (1990).
50. Won, K. A., Reed, S. I.: Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J. 15, 4182-4193 (1996).
51. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., Beach, D.: p21 is a universal inhibitor of cyclin kinases. Nature (Lond.) 366, 701-704 (1993).
52. Yin, D., Kondo, S., Barnett, G. H., Morimura, T., Takeuchi, J.: Tumor necrosis factor-alpha induces p53-dependent apoptosis in rat glioma cells. Neurosurgery 37, 758-762 (1995).
53. 6-substituted cAMP analogues on C6 glioma cells. Eur. J. Cell Biol. 60, 351-357 (1993).